益生菌中的生物活性分子对儿童健康的影响:全面审查
Linda P Guamán1, Saskya E Carrera-Pacheco1, Johana Zúñiga-Miranda1
1Centro de Investigación Biomédica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.
Nutrients
|November 9, 2024
概括
益生菌及其生物活性分子通过改善肠道微生物群和免疫功能来支持儿童健康. 后生物质药物提供了类似的好处,增强了儿童发育的安全性.
科学领域:
- 儿科健康 儿科健康
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 研究益生菌中的生物活性分子对儿童健康的影响.
- 突出了关键的代谢物,如SCFA,细菌素,EPS,维生素和GABA.
- 专注于肠道微生物群调节,免疫功能和整体发育.
研究的目的:
- 在儿科中检查益生菌和后生菌的机制和临床证据.
- 专注于促进儿童的最佳生长,发育和健康.
- 评估微生物代谢物在儿科健康中的作用.
主要方法:
- 综合了关于儿科健康的临床研究的发现.
- 专注于特定的益生菌及其对肠道健康,免疫力和发育的影响.
- 审查生物活性分子的证据及其对儿童的影响.
主要成果:
- 益生菌和代谢物减少胃肠道疾病,增强免疫力,减少过敏/感染.
- 后生菌显示出改善肠道屏障功能和减少炎症等好处.
- 与活益生菌相比,后生菌具有有利的安全性.
结论:
- 益生菌和后生菌在儿科医疗保健中显示出潜力.
- 整合可以促进儿童的最佳生长,发育和整体健康.
- 生物活性分子在儿科健康结果中起着至关重要的作用.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...


